AI Article Synopsis

  • - A 31-year-old female runner experienced left lateral calf pain for 8 months and went to physical therapy.
  • - After a month of treatment, she was referred to an orthopedic doctor, where imaging revealed a 2-cm mass in her calf muscle.
  • - The mass was diagnosed as a benign peripheral nerve sheath tumor through ultrasound and biopsy after confirming via MRI.

Article Abstract

A 31-year-old female runner presented to physical therapy via direct access with an 8-month history of atraumatic left lateral calf pain. Following 1 month of physical therapy, the patient was referred to an orthopaedic sports medicine physician. Ultrasound imaging revealed a 2-cm hypoechoic mass with well-defined margins in the left proximal lateral soleus, while Doppler ultrasound demonstrated increased color flow surrounding the mass. Magnetic resonance imaging findings were consistent with a nerve sheath tumor, and ultrasound-guided tissue biopsy determined the mass to be a benign peripheral nerve sheath tumor. J Orthop Sports Phys Ther 2017;47(2):125. doi:10.2519/jospt.2017.6780.

Download full-text PDF

Source
http://dx.doi.org/10.2519/jospt.2017.6780DOI Listing

Publication Analysis

Top Keywords

nerve sheath
12
sheath tumor
12
benign peripheral
8
peripheral nerve
8
physical therapy
8
tumor distance
4
distance runner
4
runner 31-year-old
4
31-year-old female
4
female runner
4

Similar Publications

Wallerian degeneration (WD) was first discovered by Augustus Waller in 1850 in a transection of the glossopharyngeal and hypoglossal nerves in frogs. Initial studies suggested that the formation mechanism of WD is related to the nutrition of neuronal cell bodies to axons. However, with the wide application of transgenic mice in experiments, the latest studies have found that the mechanism of WD is related to axonal degeneration, myelin clearance and extracellular matrix.

View Article and Find Full Text PDF

Adenomatous Polyposis Coli (APC) is a tumor suppressor gene expressed throughout the body. APC mutations increase the risk of malignancy and are often characterized by syndromes that encompass a spectrum of neoplastic manifestations, such as familial adenomatous polyposis (FAP). We present a rare case of palatal peripheral nerve sheath tumor in the context of APC gene mutation.

View Article and Find Full Text PDF

Objective: Increased intracranial pressure (ICP) can worsen the clinical condition of traumatic brain injury (TBI) patients. One non-invasive and easily bedside-performed technique to estimate ICP is ultrasonographic measurement of optic nerve sheath diameter (ONSD). This study aimed to analyze ONSD and correlate it with ICP values obtained by intraparenchymal monitoring to establish the ONSD threshold value for elevated ICP and reference range of ONSD in severe TBI patients.

View Article and Find Full Text PDF

Uncommon retroperitoneal mass in a young adult: A rare case report of retroperitoneal schwannoma and review of diagnostic challenges.

Int J Surg Case Rep

January 2025

General Surgery Department, Center for Traumatology and Major Burns, 1st of May Street, El Iskan City, 2013, Ben Arous, Tunisia; Faculty of Medicine of Tunis. 15, Djebel Lakhdhar Street, 1007 Bab Saadoun, Tunis, Tunisia.

Introduction And Importance: Retroperitoneal schwannomas are extremely rare, benign tumors originating from Schwann cells in peripheral nerve sheaths, with few reported cases. Their deep location and nonspecific symptoms make preoperative diagnosis challenging, often requiring imaging and surgical resection for confirmation. This case highlights an uncommon presentation of retroperitoneal schwannoma in a young patient, emphasizing its rarity.

View Article and Find Full Text PDF

NF1 encodes the multifunctional tumour suppressor protein, neurofibromin, which is best known for its causative role in Neurofibromatosis type 1 and in regulating MAPK signaling. Neurofibromin, in a context-specific manner, is involved in various tumorigenic processes, including those in melanocytes. This study investigated whether NF1 loss can collaborate with oncogenic GNAQ to promote melanoma in the dermis or eyes, where the G alpha q pathway is almost always activated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!